The establishment and further spreading of an infectious disease within a new population is a process called:

Correct Answer: A

Rationale: The correct answer is A: emergence. The term emergence refers to the process of a new infectious disease appearing and spreading within a population. It signifies the initial introduction and establishment of the disease in the new population. Explanation for other choices: B: Adoption does not accurately describe the process of a disease spreading within a new population. C: Inclusion is not a term commonly used to describe the spread of infectious diseases. D: Appearance is too vague and does not capture the complexity of the process of establishment and spreading of an infectious disease.

Correct Answer: B

Rationale: Decontamination is the reduction or removal of unwanted chemical or biological agents to make an area safe. This includes cleaning, disinfecting, or sterilizing to eliminate harmful substances. Choice A is incorrect as decontamination doesn't necessarily involve killing all microorganisms. Choice C is incorrect as it focuses on stopping growth, not removing existing contaminants. Choice D is incorrect as it specifically mentions vegetative organisms, which may not cover all types of contaminants that need to be removed during decontamination. Thus, the correct answer is B as it accurately describes the process of decontamination.

Correct Answer: D

Rationale: The correct answer is D (4) because biosafety levels range from 1 to 4, each corresponding to the level of containment required when handling different types of organisms. BSL-1 is for low-risk agents, while BSL-4 is for dangerous pathogens. Choice A (1) is incorrect as there are multiple levels, not just one. Choice B (2) and C (3) are incorrect as they do not account for all the levels of biosafety required for handling various organisms. Therefore, D is the correct answer as it encompasses the full range of biosafety levels.

Correct Answer: A

Rationale: The correct answer is A: Delayed-type hypersensitivity. The Mantoux test is a type IV hypersensitivity reaction, which is also known as delayed-type hypersensitivity. This reaction typically occurs 48-72 hours after exposure to an antigen, such as tuberculin in this case. The focal skin hardening and redness that appeared 60 hours after tuberculin introduction align with the timeline and characteristics of a delayed-type hypersensitivity reaction. Summary: - Choice A (Delayed-type hypersensitivity): Correct, as explained above. - Choice B (Immune complex-mediated hypersensitivity): Incorrect, as this reaction involves immune complexes and typically presents with tissue damage and inflammation. - Choice C (Complement-mediated cytotoxic hypersensitivity): Incorrect, as this reaction involves the activation of complement proteins leading to cell lysis. - Choice D (Immediate hypersensitivity): Incorrect, as this reaction, such as in allergies, occurs within minutes to hours of exposure to an antigen and involves IgE-mediated mast

Correct Answer: A

Rationale: The correct answer is A: Tuberculin. The Mantoux test involves injecting tuberculin, a protein derivative of Mycobacterium tuberculosis, under the skin to check for a delayed hypersensitivity reaction in individuals exposed to TB. B: BCG vaccine is a live attenuated vaccine used for TB prevention, not for diagnostic testing. C: DTP vaccine is for diphtheria, tetanus, and pertussis, not TB. D: Tularinum is not a standard immunobiological preparation used for TB testing. Therefore, A is the correct choice for the Mantoux test.